HONG KONG – A Chinese protein drug developer received a $24 million investment to prepare a new subsidiary and pave the way for an initial public offering (IPO). Read More
SHANGHAI – Hutchison China Meditech Ltd., also known as Chi-Med, said this month that phase III trials would be terminated for its lead candidate, HMPL-004, a botanical treatment for ulcerative colitis (UC). Read More
HONG KONG – A team of Korean researchers has used gene knockout techniques in mice to gain an improved understanding of the role played by the thalamic reticular nucleus (TRN) in absence seizures, which may lead to the development of effective new treatment methods for that form of epilepsy. Read More
TOKYO – Japan is now prepared to provide drugs that could help fight the outbreak of Ebola, if the World Health Organization (WHO) or other medical workers or companies request it. Read More
HONG KONG – A Chinese pharmaceutical company that went public last month in Hong Kong is expanding its pipeline through a $20 million deal that will bring a novel cancer drug from South Korea to China. Read More
SHANGHAI – Privately held Huya Bioscience International, of San Diego, has signed a strategic partnership with the Changzhou Center for Biotech Development (CZCBD) for the advancement of innovative drug and biomarker candidates. Read More
NEW DELHI – India's Central Drugs Standard Control Organisation (CDSCO) announced plans to set up an online system for submission of information on clinical trials. Read More
Polio was declared an eradicable disease in 1988, and although the global polio eradication initiative missed its original goal of wiping the disease off the face of the planet by 2000, it certainly seems possible to get there. Read More
Basilea Pharmaceutica Ltd., of Basel, Swizterland, said the EMA accepted the marketing authorization application seeking approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults. Basilea's co-development partner, Astellas Pharma Inc., of Tokyo, submitted a new drug application to the FDA in July. Read More
